Seek Labs: Michael Paul

Seek Labs, a company developing point-of-care molecular diagnostics and CRISPR-based gene therapies, has appointed Michael Paul to its board of directors. Paul is CEO, president, and director of MARAbio, a precision immunology biotechnology company developing technologies to detect maternal autoantibody related autism (MARA). Prior to this, he cofounded Lineagen in 2006, where he served as president, CEO, and director through its acquisition in 2020. He holds a BA from Colby College and a PhD in molecular biology and biochemistry from the University of Utah.